Celebrating our 10th anniversary – Unlock our special offer today

Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile database
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
News analysis
Pricing snapshots
Brand price trackers
Flavour tracker
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Philippines Upcoming enforcement of health warnings may lead to heavy fines ...
  • Europe Parliament adopts proposal to regulate ecodesign of devices ...
  • China Public comments open on amendment to e-cig transaction rules ...
  • Netherlands Health institute gives options to make e-cigs appear less attractive ...
  • United Kingdom No plans for further e-cig public use or advertising restrictions ...
  • Europe Packaging and Packaging Waste Directive revision proposal approved ...
  • Europe EU proposal for directive on corporate sustainability due diligence ...
  • Ukraine Parliament adopts bill seeking to change existing Tobacco and Alcohol Act ...
  • Europe - World WHO calls for more measures on nicotine and tobacco products ...
  • Brazil New resolution bans all types of ‘electronic smoking devices’ ...
  • United States FDA issues CMPs to retailers for unauthorised e-cig sales ...
  • Europe European Parliament adopts proposal about right to repair of goods ...
View all
News analysis

Turning Point withdraws legal action after FDA back-tracks on PMTA refusal

Written by || 12th October 2021 || News analysis | Companies | FDA | North America United States

The US Food and Drug Administration (FDA) has rescinded its marketing denial order (MDO) affecting 14 Turning Point Brands products, admitting that “relevant information that was not adequately assessed”. The company has responded by putting on hold a legal action against the agency.

In a letter to the vaping manufacturer and distributor, the FDA said the randomised trials and cross-sectional surveys that Turning Point Brands (TPB) presented in its premarket tobacco product applications (PMTAs) required “further review”.

Read full article

Download the full news analysis

“Turning Point withdraws legal action after FDA back-tracks on PMTA refusal”








    I'm already a subscriber

    Login

    Author default picture

    ECigIntelligence

    This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

    Thanks for getting in touch with us

    Please leave your enquiry and we will get back to you within 24 hours


      Sign up to our newsletter

      Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


        See more


        By signing up you agree to our Privacy Policy.